Mark Berneburg, M.D., completed his medical training as a Board-Certified Dermatologist at the Department of Dermatology at the University of Düsseldorf, Germany, under Professor Jean Krutmann and Professor Thomas Ruzicka. From March 1997 until May 1999, he carried out his scientific work as a Postdoctoral Researcher in the laboratory of Professor Alan Lehmann at the MRC Cell Mutation Unit in Brighton, UK. Currently, he works as a Clinical Consultant at the Department of Dermatology and as the Head of the Unit Molecular Oncology and Aging at the University of Tübingen, Germany. His clinical interests include photodiagnostics and phototherapy of rare hereditary skin diseases characterized by premature aging or an increased risk of skin cancer. His scientific focus is on underlying molecular mechanisms and resulting clinical consequences of genetic diseases with the aim of identifying potential therapeutic strategies. He established the role of mitochondrial (mt)DNA in premature aging of the skin as a long-term biomarker, showed a role for mtDNA mutations in skin cancer and identified a mechanism of aging associated loss of subcutaneous fat. Under his care, several preclinical and clinical studies have been carried out with patients suffering from the above diseases. He published more than 80 articles in international peer-reviewed journals, and he won several scientific prizes such as the Photoimmunological Award 2001, Skin Aging Research Award 2005 and the Fondation La Roche Posay in 2007. He serves as an Editorial Board Member of several scientific journals. He is currently Chair of the AG Genetics of the ADF and Board Member of the German Society of Photobiology.
Biography Updated on 2 March 2011